Abundance matters: role of albumin in diabetes, a proteomics perspective

References

• Fanali G, di Masi A, Trezza V, et al. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33:209–290.
   PubMed Web of Science ®Google Scholar
• Peters TJ. All about albumin: biochemistry, genetics, and medical applications. San Diego (CA): Academic Press; 1996.
   Google Scholar
• Varshney A, Sen P, Ahmad E, et al. Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality. 2010;22:77–87.
   PubMed Web of Science ®Google Scholar
• Lee P, Wu X. Review: modifications of human serum albumin and their binding effect. Curr Pharm Des. 2015;21:1862–1865.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Yamada S, Kashima M, et al. Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxid Redox Signal. 2000:681–685.
   PubMed Web of Science ®Google Scholar
• Rondeau P, Navarra G, Militello V, et al. On the aggregation of albumin: influences of the protein glycation. Protein Aggregation. 2011:139–159.
   Google Scholar
• Anguizola J, Matsuda R, Barnaby OS, et al. Review: glycation of human serum albumin. Clinica Chimica Acta. 2013;425:64–76.
   PubMed Web of Science ®Google Scholar
• Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New England J Med. 1988;318:1315–1321.
   PubMed Web of Science ®Google Scholar
• Fasano M, Curry S, Terreno E, et al. The extraordinary ligand binding properties of human serum albumin. IUBMB Life. 2005;57:787–796.
   PubMed Web of Science ®Google Scholar
• Ascenzi P, Fasano M. Allostery in a monomeric protein: the case of human serum albumin. Biophys Chem. 2010;148:16–22.
   PubMed Web of Science ®Google Scholar
• Van der Vusse GJ. Albumin as fatty acid transporter. Drug Metab Pharmacokinet. 2009;24:300–307.
   PubMed Web of Science ®Google Scholar
• Zunszain PA, Ghuman J, McDonagh AF, et al. Crystallographic analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXalpha. J Mol Biol. 2008;381:394–406.
   PubMed Web of Science ®Google Scholar
• Sjoholm I, Ekman B, Kober A, et al. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. Mol Pharmacol. 1979;16:767–777.
   PubMed Web of Science ®Google Scholar
• Ascenzi P, Fasano M. Serum heme-albumin: an allosteric protein. IUBMB Life. 2009;61:1118–1122.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang S, Huang M. Structure and enzymatic activities of human serum albumin. Curr Pharm Des. 2015;21:1831–1836.
   PubMed Web of Science ®Google Scholar
• Gundry RL, Cotter RJ. The albuminome as a tool for biomarker discovery, in Clinical Proteomics: From Diagnosis to Therapy (eds J. E. Van Eyk and M. J. Dunn), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. 2007:263–278. doi: 10.1002/9783527622153.ch18.
   Google Scholar
• Hastings GE, Wolf PG. The therapeutic use of albumin. Arch Fam Med. 1992;1:281–287.
   PubMedGoogle Scholar
• Liyasova MS, Schopfer LM, Lockridge O. Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519, and 545. Biochem Pharmacol. 2010;79:784–791.
   PubMed Web of Science ®Google Scholar
• Hawkins D, Pinckard RN, Farr RS. Acetylation of human serum albumin by acetylsalicylic acid. ScienceR (New York, NY). 1968;160:780–781.
   Web of Science ®Google Scholar
• Hawkins D, Pinckard RN, Crawford IP, et al. Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid. J Clin Investig. 1969;48:536–542.
   PubMed Web of Science ®Google Scholar
• Trynda L, Przywarska-Boniecka H, Kościukiewicz T. Influence of aspirin and iron (III) tetrasulfonated phthalocyanine on bilirubin binding by human serum albumin. J Inorg Biochem. 1990;38:153–167.
   PubMed Web of Science ®Google Scholar
• Attallah AA, Lee JB. Indomethacin, salicyclates and prostaglandin binding. Prostaglandins. 1980;19:311–318.
   PubMed Web of Science ®Google Scholar
• Rendell M, Nierenberg J, Brannan C, et al. Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo. J Lab Clin Med. 1986;108:286–293.
   PubMed Web of Science ®Google Scholar
• Hundal RS, Petersen KF, Mayerson AB, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest. 2002;109:1321–1326.
   PubMed Web of Science ®Google Scholar
• Fang F, Lu Y, Ma D-L, et al. A meta-analysis of salicylates for type 2 diabetes mellitus. J Huazhong Univ Sci Technol [Medical Sciences]. 2013;33:1–14.
   PubMed Web of Science ®Google Scholar
• Vannuruswamy G, Jagadeeshaprasad MG, Kashinath K, et al. Molecules with O-acetyl group protect protein glycation by acetylating lysine residues. RSC Adv. 2016;6:65572–65578.
   Web of Science ®Google Scholar
• Finamore F, Priego-Capote F, Gluck F, et al. Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: an in vitro study. EuPA Open Proteomics. 2014;3:100–113.
   Google Scholar
• Bar-Or D, Heyborne KD, Bar-Or R, et al. Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction. Prenat Diagn. 2005;25:245–249.
   PubMed Web of Science ®Google Scholar
• Kawakami A, Kubota K, Yamada N, et al. Identification and characterization of oxidized human serum albumin. FEBS J. 2006;273:3346–3357.
   PubMed Web of Science ®Google Scholar
• Boisvert MR, Koski KG, Skinner CD. Increased oxidative modifications of amniotic fluid albumin in pregnancies associated with gestational diabetes mellitus. Anal Chem. 2010;82:1133–1137.
   PubMed Web of Science ®Google Scholar
• Nagumo K, Tanaka M, Chuang VTG, et al. Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases. PLoS One. 2014;9:e85216.
   PubMed Web of Science ®Google Scholar
• Temple A, Yen T-Y, Gronert S. Identification of specific protein carbonylation sites in model oxidations of human serum albumin. J Am Soc Mass Spectrom. 2006;17:1172–1180.
   PubMed Web of Science ®Google Scholar
• Colombo G, Aldini G, Orioli M, et al. Water-soluble α, β-unsaturated aldehydes of cigarette smoke induce carbonylation of human serum albumin. Antioxid Redox Signal. 2006;12:349–364.
   Web of Science ®Google Scholar
• Aldini G, Regazzoni L, Orioli M, et al. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation. J Mass Spectrom. 2008;43:1470–1481.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med. 1995;46:223–234.
   PubMed Web of Science ®Google Scholar
• Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 1999;344:109–116.
   PubMed Web of Science ®Google Scholar
• Lu L, Pu LJ, Zhang Q, et al. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes. Atherosclerosis. 2009;206:540–545.
   PubMed Web of Science ®Google Scholar
• Shaklai N, Garlick RL, Bunn HF. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984;259:3812–3817.
   PubMed Web of Science ®Google Scholar
• Barnaby OS, Cerny RL, Clarke W, et al. Comparison of modification sites formed on human serum albumin at various stages of glycation. Clinica Chimica Acta. 2011;412:277–285.
   PubMed Web of Science ®Google Scholar
• Wa C, Cerny RL, Clarke WA, et al. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clinica Chimica Acta. 2007;385:48–60.
   PubMed Web of Science ®Google Scholar
• Kisugi R, Kouzuma T, Yamamoto T, et al. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clinica Chimica Acta. 2007;382:59–64.
   PubMed Web of Science ®Google Scholar
• Nakajou K, Watanabe H, Kragh-Hansen U, et al. The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochimica et Biophysica Acta (BBa)-General Subjects. 2003;1623:88–97.
   PubMed Web of Science ®Google Scholar
• Layton GJ, Jerums G. Effect of glycation of albumin on its renal clearance in normal and diabetic rats. Kidney Int. 1988;33:673–676.
   PubMed Web of Science ®Google Scholar
• Gugliucci A, Bendayan M. Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia. 1996;39:149–160.
   PubMed Web of Science ®Google Scholar
• Bucala R, Makita Z, Vega G, et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci. 1994;91:9441–9445.
   PubMed Web of Science ®Google Scholar
• Dobrian A, Simionescu M. Irreversibly glycated albumin alters the physico-chemical characteristics of low density lipoproteins of normal and diabetic subjects. Biochimica et Biophysica Acta (BBa)-Molecular Basis of Disease. 1995;1270:26–35.
   PubMed Web of Science ®Google Scholar
• Thornalley PJ. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol (Noisy-Le-Grand). 2003;44:1013–1023.
   Google Scholar
• Horiuchi S, Sakamoto Y, Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids. 2003;25:283–292.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Brownlee M, Cerami A. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci. 1985;82:5588–5592.
   PubMed Web of Science ®Google Scholar
• Ohgami N, Nagai R, Miyazaki A, et al. Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products. J Biol Chem. 2001;276:13348–13355.
   PubMed Web of Science ®Google Scholar
• Ohgami N, Nagai R, Ikemoto M, et al. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem. 2001;276:3195–3202.
   PubMed Web of Science ®Google Scholar
• Von Zastrow M, Sorkin A. Signaling on the endocytic pathway. Curr Opin Cell Biol. 2007;19:436–445.
   PubMed Web of Science ®Google Scholar
• Platta HW, Stenmark H. Endocytosis and signaling. Curr Opin Cell Biol. 2011;23:393–403.
   PubMed Web of Science ®Google Scholar
• Grimm S, Horlacher M, Catalgol BL, et al. Cathepsins D and L reduce the toxicity of advanced glycation end products. Free Radic Biol Med. 2012;52:1011–1023.
   PubMed Web of Science ®Google Scholar
• Vlassara H. The AGE receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev. 2001;17:436–443.
   PubMed Web of Science ®Google Scholar
• H-J Y, Y-H L, Kim SR, et al. Glycated albumin and the risk of micro-and macrovascular complications in subjects with type 1 diabetes. Cardiovasc Diabetol. 2015;14:53.
   PubMed Web of Science ®Google Scholar
• Miyata S, Liu B-F, Shoda H, et al. Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes. J Biol Chem. 1997;272:4037–4042.
   PubMed Web of Science ®Google Scholar
• Ghiggeri GM, Candiano G, Delfino G, et al. Glycosyl albumin and diabetic microalbuminuria: demonstration of an altered renal handling. Kidney Int. 1984;25:565–570.
   PubMed Web of Science ®Google Scholar
• Nicoloff G, Baydanoff S, Petrova C, et al. Antibodies to advanced glycation end products in children with diabetes mellitus. Vascul Pharmacol. 2002;39:39–45.
   PubMed Web of Science ®Google Scholar
• Lopes-Virella MF, Baker NL, Hunt KJ, et al. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care. 2012;35:1333–1340.
   PubMed Web of Science ®Google Scholar
• Schalkwijk CG, Ligtvoet N, Twaalfhoven H, et al. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes. 1999;48:2446–2453.
   PubMed Web of Science ®Google Scholar
• Khan MWA, Qadrie ZL, Khan WA. Antibodies against gluco-oxidatively modified human serum albumin detected in diabetes-associated complications. Int Arch Allergy Immunol. 2010;153:207–214.
   PubMed Web of Science ®Google Scholar
• Turk Z, Ljubic S, Turk NA, et al. Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus. Clinica Chimica Acta. 2001;303:105–115.
   PubMed Web of Science ®Google Scholar
• Cornacoff JB, Hebert LA, Smead WL, et al. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest. 1983;71:236–247.
   PubMed Web of Science ®Google Scholar
• Velez MG, Bhalla V. The role of the immune system in the pathogenesis of diabetic nephropathy. J Nephrol Therapeutic. 2012;5:2161–2959.
   Google Scholar
• Bhat S, Jagadeeshaprasad MG, Patil YR, et al. Proteomic insight reveals elevated levels of albumin in circulating immune complexes in diabetic plasma. Mol Cell Proteomics. 2016;15:2011–2020.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Yan SF, Schmidt AM. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann NY Acad Sci. 2011;1243:88–102.
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Hori O, Chen JX, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995;96:1395–1403.
   PubMed Web of Science ®Google Scholar
• Kislinger T, Fu C, Huber B, et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1994;274:31740–31749.
   Web of Science ®Google Scholar
• Huang JS, Guh JY, Chen HC, et al. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem. 2001;81:102–113.
   PubMed Web of Science ®Google Scholar
• Arif B, Ashraf JM, Ahmad J, et al. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus. Arch Biochem Biophys. 2012;522:17–25.
   PubMed Web of Science ®Google Scholar
• Barnaby OS, Wa C, Cerny RL, et al. Quantitative analysis of glycation sites on human serum albumin using 16 O/18 O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clinica Chimica Acta. 2010;411:1102–1110.
   PubMed Web of Science ®Google Scholar
• Westwood ME, Thornalley PJ. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J Protein Chem. 1995;14:359–372.
   PubMedGoogle Scholar
• Okabe N, Hashizume N. Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism. Biol Pharm Bull. 1994;17:16–21.
   PubMed Web of Science ®Google Scholar
• Howard MJ, Smales CM. NMR analysis of synthetic human serum albumin alpha-helix 28 identifies structural distortion upon amadori modification. J Biol Chem. 2005:22582–22589.
   PubMed Web of Science ®Google Scholar
• Lapolla A, Gerhardinger C, Baldo L, et al. A study on in vitro glycation processes by matrix-assisted laser desorption ionization mass spectrometry. Biochim Biophys Acta. 1993;1225:33–38.
   PubMed Web of Science ®Google Scholar
• Barnaby OS, Cerny RL, Clarke W, et al. Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS. Clinica Chimica Acta. 2011;412:1606–1615.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Tang N, Brock JWC, et al. Enrichment and analysis of nonenzymatically glycated peptides: boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry. J Proteome Res. 2007;6:2323–2330.
   PubMed Web of Science ®Google Scholar
• Frolov A, Hoffmann P, Hoffmann R. Fragmentation behavior of glycated peptides derived from D-glucose, D-fructose and D-ribose in tandem mass spectrometry. J Mass Spectrom. 2006;41:1459–1469.
   PubMed Web of Science ®Google Scholar
• Lapolla A, Fedele D, Reitano R, et al. Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectrom. 2004;15:496–509.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Dobler D, Dean M, et al. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem. 2005;280:5724–5732.
   PubMed Web of Science ®Google Scholar
• Gadgil HS, Bondarenko PV, Treuheit MJ, et al. Screening and sequencing of glycated proteins by neutral loss scan LC/MS/MS method. Anal Chem. 2007;79:5991–5999.
   PubMed Web of Science ®Google Scholar
• Frolov A, Hoffmann R. Identification and relative quantification of specific glycation sites in human serum albumin. Anal Bioanal Chem. 2010;397:2349–2356.
   PubMed Web of Science ®Google Scholar
• Stefanowicz P, Kijewska M, Kluczyk A, et al. Detection of glycation sites in proteins by high-resolution mass spectrometry combined with isotopic labeling. Anal Biochem. 2010;400:237–243.
   PubMed Web of Science ®Google Scholar
• Bhonsle HS, Korwar AM, Kote SS, et al. Low plasma albumin levels are associated with increased plasma protein glycation and HbA1c in diabetes. J Proteome Res. 2012;11:1391–1396.
   PubMed Web of Science ®Google Scholar
• Korwar AM, Vannuruswamy G, Jagadeeshaprasad MG, et al. Development of diagnostic fragment ion library for glycated peptides of human serum albumin: targeted quantification in prediabetic, diabetic, and microalbuminuria plasma by parallel reaction monitoring, SWATH, and MSE. Mol Cell Proteomics. 2015;14:2150–2159.
   PubMed Web of Science ®Google Scholar
• Brede C, Hop B, Jørgensen K, et al. Measurement of glycated albumin in serum and plasma by LC-MS/MS. Scand J Clin Lab Invest. 2016;76:195–201.
   PubMed Web of Science ®Google Scholar
• Soboleva A, Modzel M, Didio A, et al. Quantification of prospective type 2 diabetes mellitus biomarkers by stable isotope dilution with bi-labeled standard glycated peptides. Anal Methods. 2017;9:409–418.
   Web of Science ®Google Scholar
• Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008;112:4284–4291.
   PubMed Web of Science ®Google Scholar
• Cohen RM, Sacks DB. Comparing multiple measures of glycemia: how to transition from biomarker to diagnostic test? Clinical Chemistry. 2012;58:1615–1617.
   PubMed Web of Science ®Google Scholar
• Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care. 2011;34:518–523.
   PubMed Web of Science ®Google Scholar
• Wright LA-C, Hirsch IB. The challenge of the use of glycemic biomarkers in diabetes: reflecting on hemoglobin A1C, 1, 5-anhydroglucitol, and the glycated proteins fructosamine and glycated albumin. Diabetes Spectrum. 2012;25:141–148.
   Google Scholar
• Tylee TS, Trence DL. Glycemic variability: looking beyond the A1C. Diabetes Spectrum. 2012;25:149–153.
   Google Scholar
• Bhonsle HS, Singh SK, Srivastava G, et al. Albumin competitively inhibits glycation of less abundant proteins. Protein Pept Lett. 2008;15:663–667.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Uchino H, Shimizu T, et al. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J. 2007;54:139–144.
   PubMed Web of Science ®Google Scholar
• Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clinical Chemistry. 1987;33:2153–2163.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Segade S, Lojo S, Camina MF, et al. Effects of various serum proteins on quantification of fructosamine. Clinical Chemistry. 1989;35:134–138.
   PubMed Web of Science ®Google Scholar
• Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J. 2010;57:751–762.
   PubMed Web of Science ®Google Scholar
• Paroni R, Ceriotti F, Galanello R, et al. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007;40:1398–1405.
   PubMed Web of Science ®Google Scholar
• Kouzuma T, Usami T, Yamakoshi M, et al. An enzymatic method for the measurement of glycated albumin in biological samples. Clinica Chimica Acta. 2002;324:61–71.
   PubMed Web of Science ®Google Scholar
• Sumner AE, Duong MT, Aldana PC, et al. A1C combined with glycated albumin improves detection of prediabetes in Africans: the Africans in America study. Diabetes Care. 2016;39:271–277.
   PubMed Web of Science ®Google Scholar
• Chujo K, Shima K, Tada H, et al. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Investig. 2006;53:223–228.
   PubMedGoogle Scholar
• Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007;18:896–903.
   PubMed Web of Science ®Google Scholar
• Wang N, Xu Z, Han P, et al. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus. Diabetes Metab Res Rev. 2017;33:e2843. [Epub 2016 Sep 26].
   Web of Science ®Google Scholar
• Umayahara Y, Fujita Y, Watanabe H, et al. Association of glycated albumin to HbA1c ratio with diabetic retinopathy but not diabetic nephropathy in patients with type 2 diabetes. Clin Biochem. 2016;60:30390–30393.
   Google Scholar
• Song SO, Kim KJ, Lee B-W, et al. Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis. 2012;225:450–455.
   PubMed Web of Science ®Google Scholar
• Furusyo N, Koga T, Ai M, et al. Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS). Int J Cardiol. 2013;167:2066–2072.
   PubMed Web of Science ®Google Scholar
• Wang N, Guo C, Han P, et al. Glycated albumin indicates peripheral diabetic neuropathy. Acta Diabetol. 2016;53:973–979.
   PubMed Web of Science ®Google Scholar
• Selvin E, Rawlings AM, Grams M, et al. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol. 2014;2:279–288.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Noguchi S, Morimoto Y, et al. A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care. 2008;31:1945–1948.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Osugi T, Noguchi S, et al. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care. 2008;33:509–511.
   Web of Science ®Google Scholar
• Flaim KE, Hutson SM, Lloyd CE, et al. Direct effect of insulin on albumin gene expression in primary cultures of rat hepatocytes. Am J Physiology-Endocrinology Metabolism. 1985;249:E447–E53.
   PubMed Web of Science ®Google Scholar
• Jefferson LS, Liao WS, Peavy DE, et al. Diabetes-induced alterations in liver protein synthesis. Changes in the relative abundance of mRNAs for albumin and other plasma proteins. J Biol Chem. 1983;258:1369–1375.
   PubMed Web of Science ®Google Scholar
• Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85:599–610.
   PubMed Web of Science ®Google Scholar
• Merlot AM, Kalinowski DS, Richardson DR. Unraveling the mysteries of serum albumin-more than just a serum protein. Front Physiol. 2014;5:299.
   Google Scholar
• Stehle G, Sinn H, Wunder A, et al. Plasma protein (albumin) catabolism by the tumor itself–implications for tumor metabolism and the genesis of cachexia. Crit Rev Oncol Hematol. 1997;26:77–100.
   PubMed Web of Science ®Google Scholar
• Viswanathan V, Snehalatha C, Kumutha R, et al. Serum albumin levels in different stages of type 2 diabetic nephropathy patients. Indian J Nephrol. 2004;14:89–92.
   Google Scholar
• Rodríguez-Segade S, Rodríguez J, Mayan D, et al. Plasma albumin concentration is a predictor of HbA1c among type 2 diabetic patients, independently of fasting plasma glucose and fructosamine. Diabetes Care. 2005;28:437–439.
   PubMed Web of Science ®Google Scholar
• Jellinge ME, Henriksen DP, Hallas P, et al. Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: a prospective, observational, cohort study. PLoS One. 2014;9:e105983.
   PubMed Web of Science ®Google Scholar
• Nathan DM, McGee P, Steffes MW, et al. Relationship of glycated albumin to blood glucose and glycated hemoglobin (HbA1C) values and to retinopathy, nephropathy and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014;63:282–289.
   PubMed Web of Science ®Google Scholar
• Tiwari S, Bothale M, Hasan I, et al. Association between serum albumin and glycated hemoglobin in Asian Indian subjects. Indian J Endocrinol Metab. 2014;19:52–55.
   Google Scholar
• Jagadeeshaprasad MG, Batkulwar KB, Meshram NN, et al. Targeted quantification of N-1-(carboxymethyl) valine and N-1-(carboxyethyl) valine peptides of β-hemoglobin for better diagnostics in diabetes. Clin Proteomics. 2016;13:7.
   PubMed Web of Science ®Google Scholar
• Sviridov D, Drake SK, Hortin GL. Reactivity of urinary albumin (microalbumin) assays with fragmented or modified albumin. Clinical Chemistry. 2008;54:61–68.
   PubMed Web of Science ®Google Scholar